← Back to All Filings

OHI CEO Awarded Equity Grant; Potential 19.4% Dilution Impact

High SignificanceJanuary 15, 2026 at 6:31:56 PM EST

OMEGA HEALTHCARE INVESTORS INC

$OHI4CIK: 0000888491

Subscribe to track OHI

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

OHI CEO Awarded Equity Grant; Potential 19.4% Dilution Impact

Company: OMEGA HEALTHCARE INVESTORS INC (OHI) Form: 4 | Filed: 2026/01/15 Significance: High

Insider: PICKETT C TAYLOR Title: CHIEF EXECUTIVE OFFICER | Relationship: Director, Officer

Transaction: • Type: Grant • Shares: 57,331 • Price: $0.00 • Value: $0 • Owned After: 569,974 units

Key Insight: The CEO received an equity grant representing 19.4% of the company's stated shares outstanding, a highly significant potential dilution event based on provided market data.

Market Context: This is a long-term incentive in the form of Profits Interest Units, which vest in late 2028, intended to align executive interests with long-term shareholder value.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: OMEGA HEALTHCARE INVESTORS INC (OHI)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: The CEO was awarded equity representing 19.4% of the company's stated shares outstanding, a highly material grant that signals significant potential future dilution.
  • Market Impact: Neutral in the short term, as this is a non-market transaction with a long vesting period, but highlights a major potential increase in share count.

Company Information

FieldValue
CompanyOMEGA HEALTHCARE INVESTORS INC
Ticker SymbolOHI
CIK0000888491
IndustryREAL ESTATE INVESTMENT TRUSTS

Insider Information

FieldValue
NamePICKETT C TAYLOR
CIK0001143567
Title/PositionCHIEF EXECUTIVE OFFICER
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-01-13
Transaction CodeA (Grant)
Security TypeProfits Interest Units
Shares Involved57,331
Price Per Share$0.00
Total Value$0
Shares Owned After569,974
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted57,331
% of Shares Outstanding19.43%
Post-Transaction Ownership569,974 units (193.21% of outstanding)
Materiality AssessmentHighly Significant

Impact Evaluation

  • Market Cap Context: While the grant has a transaction value of $0, its size relative to the shares outstanding makes it noteworthy for a company with a $12.99 billion market capitalization.
  • Ownership Concentration: Based on the provided shares outstanding data, the CEO's post-transaction holdings of 569,974 units would represent an impossible 193.21% of the company. This highlights a likely discrepancy in the source market data, but the grant itself still represents a substantial increase in the CEO's potential equity stake.
  • Dilution Impact: The grant of 57,331 shares represents a potential dilution of 19.43% to existing shareholders. This is an exceptionally high level of dilution from a single compensation-related event and is the primary driver of the 'High' significance rating.
  • Transaction Significance: The transaction is deemed 'Highly Significant' not due to its dollar value, but because the number of shares granted exceeds the 0.5% threshold of shares outstanding by a very large margin.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a scheduled executive compensation grant, not an open-market transaction reflecting immediate insider sentiment. The impact is deferred until the shares vest in late 2028.

Volume & Sentiment

  • Expected Volume Impact: None. This is a non-market transaction and does not directly impact trading volume.
  • Sentiment Indicator: Neutral. While the size of the grant is alarming from a dilution perspective, such long-term incentive plans are standard practice to align executive and shareholder interests.

Investment Insights

Positive Market Indicators

  • The grant structure with a three-year vesting cliff aligns the CEO's compensation with the long-term performance of the company.

Risk Factors

  • The primary risk is the extreme potential dilution of 19.43% upon vesting, which could place downward pressure on the stock price if not matched by corresponding growth in company value.
  • The post-transaction ownership percentage calculated from the provided data is illogical, suggesting a potential issue with the shares outstanding figure used for this analysis.

Key Takeaways

  1. OHI's CEO, C. Taylor Pickett, received a grant of 57,331 Profits Interest Units.
  2. The grant represents a potential 19.43% dilution to shareholders, making it a highly significant event based on the provided data.
  3. The units are a form of long-term incentive and will not vest until December 31, 2028, delaying any market impact.

Additional Context

Transaction Notes

  • The securities are Profits Interest Units (PIUs), which are convertible into OP Units. Each OP Unit is redeemable for one share of OHI common stock, making them economically equivalent to a stock grant upon vesting.
Topics:#SECFiling#InsiderTrading#OHI#OmegaHealthcare#Form4#EquityGrant#CEO#StockMarket#Investing#HighSignificance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.